Declining seroprevalence in a very large HIV epidemic: Injecting drug users in New York City, 1991 to 1996

Don C. Des Jarlais, Theresa Perlis, Samuel R. Friedman, Sherry Deren, Timothy Chapman, Jo L. Sotheran, Stephanie Tortu, Mark Beardsley, Denise Paone, Lucia V. Torian, Sara T. Beatrice, Erica DeBernardo, Edgar Monterroso, Michael Marmor

Research output: Contribution to journalArticle

Abstract

Objectives. This study assessed recent trends in HIV seroprevalence among injecting drug users in New York City. Methods. We analyzed temporal trends in HIV seroprevalence from 1991 through 1996 in 5 studies of injecting drug users recruited from a detoxification program, a methadone maintenance program, research store-fronts in the Lower East Side and Harlem areas, and a citywide network of sexually transmitted disease clinics. A total of 11 334 serum samples were tested. Results. From 1991 through 1996, HIV seroprevalence declined substantially among subjects in all 5 studies: from 53% to 36% in the detoxification program, from 45% to 29% in the methadone program, from 44% to 22% at the Lower East Side storefront, from 48% to 21% at the Harlem storefront, and from 30% to 21% in the sexually transmitted disease clinics (all P <.002 by x 2 tests for trend). Conclusions. The reductions in HIV seroprevalence seen among injecting drug users in New York City from 1991 through 1996 indicate a new phase in this large HIV epidemic. Potential explanatory factors include the loss of seropositive individuals through disability and death and lower rates of risk behavior leading to low HIV incidence.

Original languageEnglish (US)
Pages (from-to)1801-1806
Number of pages6
JournalAmerican Journal of Public Health
Volume88
Issue number12
StatePublished - 1998

Fingerprint

HIV Seroprevalence
Seroepidemiologic Studies
Drug Users
HIV
Methadone
Sexually Transmitted Diseases
Risk-Taking
Mortality
Incidence
Serum
Research

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health

Cite this

Des Jarlais, D. C., Perlis, T., Friedman, S. R., Deren, S., Chapman, T., Sotheran, J. L., ... Marmor, M. (1998). Declining seroprevalence in a very large HIV epidemic: Injecting drug users in New York City, 1991 to 1996. American Journal of Public Health, 88(12), 1801-1806.

Declining seroprevalence in a very large HIV epidemic : Injecting drug users in New York City, 1991 to 1996. / Des Jarlais, Don C.; Perlis, Theresa; Friedman, Samuel R.; Deren, Sherry; Chapman, Timothy; Sotheran, Jo L.; Tortu, Stephanie; Beardsley, Mark; Paone, Denise; Torian, Lucia V.; Beatrice, Sara T.; DeBernardo, Erica; Monterroso, Edgar; Marmor, Michael.

In: American Journal of Public Health, Vol. 88, No. 12, 1998, p. 1801-1806.

Research output: Contribution to journalArticle

Des Jarlais, DC, Perlis, T, Friedman, SR, Deren, S, Chapman, T, Sotheran, JL, Tortu, S, Beardsley, M, Paone, D, Torian, LV, Beatrice, ST, DeBernardo, E, Monterroso, E & Marmor, M 1998, 'Declining seroprevalence in a very large HIV epidemic: Injecting drug users in New York City, 1991 to 1996', American Journal of Public Health, vol. 88, no. 12, pp. 1801-1806.
Des Jarlais, Don C. ; Perlis, Theresa ; Friedman, Samuel R. ; Deren, Sherry ; Chapman, Timothy ; Sotheran, Jo L. ; Tortu, Stephanie ; Beardsley, Mark ; Paone, Denise ; Torian, Lucia V. ; Beatrice, Sara T. ; DeBernardo, Erica ; Monterroso, Edgar ; Marmor, Michael. / Declining seroprevalence in a very large HIV epidemic : Injecting drug users in New York City, 1991 to 1996. In: American Journal of Public Health. 1998 ; Vol. 88, No. 12. pp. 1801-1806.
@article{ebb537ee0df641f892927cfabfe7daff,
title = "Declining seroprevalence in a very large HIV epidemic: Injecting drug users in New York City, 1991 to 1996",
abstract = "Objectives. This study assessed recent trends in HIV seroprevalence among injecting drug users in New York City. Methods. We analyzed temporal trends in HIV seroprevalence from 1991 through 1996 in 5 studies of injecting drug users recruited from a detoxification program, a methadone maintenance program, research store-fronts in the Lower East Side and Harlem areas, and a citywide network of sexually transmitted disease clinics. A total of 11 334 serum samples were tested. Results. From 1991 through 1996, HIV seroprevalence declined substantially among subjects in all 5 studies: from 53{\%} to 36{\%} in the detoxification program, from 45{\%} to 29{\%} in the methadone program, from 44{\%} to 22{\%} at the Lower East Side storefront, from 48{\%} to 21{\%} at the Harlem storefront, and from 30{\%} to 21{\%} in the sexually transmitted disease clinics (all P <.002 by x 2 tests for trend). Conclusions. The reductions in HIV seroprevalence seen among injecting drug users in New York City from 1991 through 1996 indicate a new phase in this large HIV epidemic. Potential explanatory factors include the loss of seropositive individuals through disability and death and lower rates of risk behavior leading to low HIV incidence.",
author = "{Des Jarlais}, {Don C.} and Theresa Perlis and Friedman, {Samuel R.} and Sherry Deren and Timothy Chapman and Sotheran, {Jo L.} and Stephanie Tortu and Mark Beardsley and Denise Paone and Torian, {Lucia V.} and Beatrice, {Sara T.} and Erica DeBernardo and Edgar Monterroso and Michael Marmor",
year = "1998",
language = "English (US)",
volume = "88",
pages = "1801--1806",
journal = "American Journal of Public Health",
issn = "0090-0036",
publisher = "American Public Health Association Inc.",
number = "12",

}

TY - JOUR

T1 - Declining seroprevalence in a very large HIV epidemic

T2 - Injecting drug users in New York City, 1991 to 1996

AU - Des Jarlais, Don C.

AU - Perlis, Theresa

AU - Friedman, Samuel R.

AU - Deren, Sherry

AU - Chapman, Timothy

AU - Sotheran, Jo L.

AU - Tortu, Stephanie

AU - Beardsley, Mark

AU - Paone, Denise

AU - Torian, Lucia V.

AU - Beatrice, Sara T.

AU - DeBernardo, Erica

AU - Monterroso, Edgar

AU - Marmor, Michael

PY - 1998

Y1 - 1998

N2 - Objectives. This study assessed recent trends in HIV seroprevalence among injecting drug users in New York City. Methods. We analyzed temporal trends in HIV seroprevalence from 1991 through 1996 in 5 studies of injecting drug users recruited from a detoxification program, a methadone maintenance program, research store-fronts in the Lower East Side and Harlem areas, and a citywide network of sexually transmitted disease clinics. A total of 11 334 serum samples were tested. Results. From 1991 through 1996, HIV seroprevalence declined substantially among subjects in all 5 studies: from 53% to 36% in the detoxification program, from 45% to 29% in the methadone program, from 44% to 22% at the Lower East Side storefront, from 48% to 21% at the Harlem storefront, and from 30% to 21% in the sexually transmitted disease clinics (all P <.002 by x 2 tests for trend). Conclusions. The reductions in HIV seroprevalence seen among injecting drug users in New York City from 1991 through 1996 indicate a new phase in this large HIV epidemic. Potential explanatory factors include the loss of seropositive individuals through disability and death and lower rates of risk behavior leading to low HIV incidence.

AB - Objectives. This study assessed recent trends in HIV seroprevalence among injecting drug users in New York City. Methods. We analyzed temporal trends in HIV seroprevalence from 1991 through 1996 in 5 studies of injecting drug users recruited from a detoxification program, a methadone maintenance program, research store-fronts in the Lower East Side and Harlem areas, and a citywide network of sexually transmitted disease clinics. A total of 11 334 serum samples were tested. Results. From 1991 through 1996, HIV seroprevalence declined substantially among subjects in all 5 studies: from 53% to 36% in the detoxification program, from 45% to 29% in the methadone program, from 44% to 22% at the Lower East Side storefront, from 48% to 21% at the Harlem storefront, and from 30% to 21% in the sexually transmitted disease clinics (all P <.002 by x 2 tests for trend). Conclusions. The reductions in HIV seroprevalence seen among injecting drug users in New York City from 1991 through 1996 indicate a new phase in this large HIV epidemic. Potential explanatory factors include the loss of seropositive individuals through disability and death and lower rates of risk behavior leading to low HIV incidence.

UR - http://www.scopus.com/inward/record.url?scp=0032445510&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032445510&partnerID=8YFLogxK

M3 - Article

C2 - 9842377

AN - SCOPUS:0032445510

VL - 88

SP - 1801

EP - 1806

JO - American Journal of Public Health

JF - American Journal of Public Health

SN - 0090-0036

IS - 12

ER -